Skip to main content

Abstract

The role of radiotherapy (RT) for metastatic breast cancer is broken down into three settings: the first and most common is palliative radiotherapy, the second is stereotactic RT for oligometastases instead of surgery, and the third is the irradiation of the breast for locoregional control. The goal of treatment is to prolong survival, to lengthen the time to progression, to provide relief for disease-related symptoms, and to improve the quality of life of the metastatic patient. Nevertheless, treatment modalities with minimal toxicity are preferred for each patient on an individual basis. A multidisciplinary team including a medical oncologist, a radiation oncologist, a breast surgeon, and a psychiatrist is necessary for guiding optimal treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ashby M. The role of radiotherapy in palliative care. J Pain Symptom Manage. 1991;6:229–38.

    Article  Google Scholar 

  2. Souchon R, Wenz F, Sedlmayer F, et al. DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer. Strahlenther Oncol. 2009;7:417–24.

    Article  Google Scholar 

  3. Gaze MN, Kelly CG, Kerr GR, et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomized trial of two fractionation schedules. Radiother Oncol. 1997;45:109–16.

    Article  PubMed  CAS  Google Scholar 

  4. Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short versus long course radiotherapy for palliation of painful bone metastases. Natl Cancer Inst. 2005;97:798–804.

    Article  Google Scholar 

  5. Chow E, Haris K, Fan G, et al. Palliative radiotherapy for bone metastases: a systematic review. J Clin Oncol. 2007;25:1423–36.

    Article  PubMed  Google Scholar 

  6. Ozsaran Z, Yalman D, Anacak Y, et al. Palliative radiotherapy in bone metastases: results of a randomized trial comparing three fractionation schedules. J BUON. 2001;6:43–8.

    Google Scholar 

  7. Lutz S, Berk L, Chang E, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence based guideline. Int J Radiat Oncol Biol Phys. 2011;79:065–76.

    Article  Google Scholar 

  8. Ren Y, Ma L, Tian J, et al. A systematic review on different treatment methods of bone metastasis from cancer. Zhangguou FeiAiZaZhi. 2010;13:533–9.

    Google Scholar 

  9. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf (2011). Accessed 13.11.2011.

  10. Niang U, Kamer S, Özsaran Z, et al. The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases. J BUON. 2009;14:245–9.

    PubMed  CAS  Google Scholar 

  11. Poznak CHV, Temin S, Yee GC, et al. American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone modifying agent in metastatic breast cancer. JCO. 2010;29:1221–7.

    Article  Google Scholar 

  12. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Eng J Med. 1990;322:494–500.

    Article  CAS  Google Scholar 

  13. Graham PH, Bucci J, Browne L. Randomized comparison of whole brain radiıotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice daily fractions for brain metastases. Int J Radiat Oncol Biol Phys. 2010;77:648–54.

    Article  PubMed  CAS  Google Scholar 

  14. Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management of patients newly diagnosed brain metastases a systematic review and evidence based clinical practice guideline. J Neurooncol. 2010;96:69–70.

    Article  Google Scholar 

  15. Milano MT, Zhang H, Metcalfe SK, et al. Oligometastatic breast cancer treated with curative-intent stereotactic radiation therapy. Breast Cancer Res Treat. 2009;115:601–8.

    Article  PubMed  Google Scholar 

  16. Scodan RL, Stevens D, Brain E, et al. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy. J Clin Oncol. 2009;27:1375–81.

    Article  PubMed  Google Scholar 

  17. Soran A, Özbaş S, Kelsey SF, Güllüoğlu B. Randomized trial comparing locoregional resection of primary tumor with no surgery in stage IV breast cancer at the presentation (protocol MF07-01): a study of Turkish Federation of the National Societies for Breast Disease. Breast J. 2009;15:399–403.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zeynep Ozsaran .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ozsaran, Z., Alanyalı, S.D. (2013). Metastatic Breast Cancer. In: Haydaroglu, A., Ozyigit, G. (eds) Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5116-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-5116-7_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-5115-0

  • Online ISBN: 978-1-4614-5116-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics